Characterization of potential elastase inhibitor-peptides regulated by a molecular switch for wound dressings applications

Enzyme and Microbial Technology

Volumn 50, Issue 2, 2012, Pages 107-114

  Barros, Sandra Cerqueira ^a   Martins, José Alberto ^a   Marcos, João Carlos ^a   Cavaco Paulo, Artur ^a  

^a UNIVERSITY OF MINHO   (Portugal)

Author keywords

Elastase; Inhibitor peptides; Luminometry; Micro arrays; Phosphorylation; Wound dressings

Indexed keywords

CASEIN KINASE I; CHRONIC WOUNDS; CYSTEINE RESIDUES; DEGRADATION STUDY; ELASTASE; ENDOGENOUS INHIBITOR; HEALTHY TISSUES; HUMAN NEUTROPHIL ELASTASE; INHIBITOR-PEPTIDES; INHIBITORY ACTIVITY; LUMINOMETRY; METHIONINE RESIDUES; MOLECULAR SWITCHES; PEPTIDE LIBRARY; POTENTIAL INHIBITORS; REVERSIBLE PROCESS; TISSUE RECOVERY; WOUND DRESSINGS; WOUND HEALING PROCESS;

AMINO ACIDS; ENZYMES; PHOSPHORYLATION; TISSUE;

PEPTIDES;

CASEIN KINASE IDELTA; CYSTEINE DERIVATIVE; ELASTASE; ELASTASE INHIBITOR; METHIONINE DERIVATIVE; PEPTIDE 4; PEPTIDE 4 MODIFIED; PEPTIDE DERIVATIVE; PROTEIN KINASE; UNCLASSIFIED DRUG;

ARTICLE; CHRONIC WOUND; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME PHOSPHORYLATION; MICROARRAY ANALYSIS; MOLECULAR DYNAMICS; MOLECULAR SWITCH; NONHUMAN; PEPTIDE ANALYSIS; PEPTIDE LIBRARY; PROTEIN DEPHOSPHORYLATION; WOUND DRESSING; WOUND FLUID;

ANIMALS; BANDAGES; BIOTECHNOLOGY; CASEIN KINASE IDELTA; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OLIGOPEPTIDES; PANCREATIC ELASTASE; PEPTIDE LIBRARY; PEPTIDES; PHOSPHORYLATION; SUBSTRATE SPECIFICITY; WOUND HEALING;

EID: 84855432805     PISSN: 01410229     EISSN: 18790909     Source Type: Journal    
DOI: 10.1016/j.enzmictec.2011.10.006     Document Type: Article

References (47)

1. Braund R., Hook S., Medlicott N.J. The role of topical growth factors in chronic wounds. Current Drug Delivery 2007, 4:195-204.
2. Schonfelder U., Abel M., Wiegand C., Klemm D., Elsner P., Hipler U.C. Influence of selected wound dressings on PMN elastase in chronic wound fluid and their antioxidative potential in vitro. Biomaterials 2005, 26:6664-6673.
3. Yager D.R., Chen S.M., Ward S.I., Olutoye O.O., Diegelmann R.F., Kelman Cohen I. Ability of chronic wound fluids to degrade peptide growth factors is associated with increased levels of elastase activity and diminished levels of proteinase inhibitors. Wound Repair and Regeneration 1997, 5:23-32.
4. Wiegand C., Schönfelder U., Abel M., Ruth P., Kaatz M., Hipler U.-C. Protease and pro-inflammatory cytokine concentrations are elevated in chronic compared to acute wounds and can be modulated by collagen type I in vitro. Archives of Dermatological Research 2010, 302:419-428.
5. Edwards J.V., Howley P., Cohen I.K. In vitro inhibition of human neutrophil elastase by oleic acid albumin formulations from derivatized cotton wound dressings. International Journal of Pharmaceutics 2004, 284:1-12.
6. Fitch P.M., Roghanian A., Howie S.E.M., Sallenave J.M. Human neutrophil elastase inhibitors in innate and adaptive immunity. Biochemical Society Transactions 2006, 34:279-282.
7. Edwards J.V., Bopp A., Yachmenev V., Goheen S., Yager D., Cohen I. Research and development of an active cotton-based wound dressing for use in chronic wounds. Beltwide Cotton Textile Processing Conference Proceedings 2004, 2851-2855.
8. Vincent E.J., Alvin F.B., Sarah B., Abul J.U., Kelman C.I., Robert F.D., et al. Inhibition of elastase by a synthetic cotton-bound serine protease inhibitor: in vitro kinetics and inhibitor release. Wound Repair and Regeneration 1999, 7:106-118.
9. Edwards J.V., Eggleston G., Yager D.R., Cohen I.K., Diegelmann R.F., Bopp A.F. Design, preparation and assessment of citrate-linked monosaccharide cellulose conjugates with elastase-lowering activity. Carbohydrate Polymers 2002, 50:305-314.
10. Edwards J.V., Yager D.R., Cohen I.K., Diegelmann R.F., Montante S., Bertoniere N., et al. Modified cotton gauze dressings that selectively absorb neutrophil elastase activity in solution. Wound Repair and Regeneration 2001, 9:50-58.
11. Edwards J.V., Phyllis S.H. Human neutrophil elastase and collagenase sequestration with phosphorylated cotton wound dressings. Journal of Biomedical Materials Research Part A 2007, 83A:446-454.
12. Annie J., David V. Hydrogel dressings in the management of a variety of wound types: a review. Journal of Orthopaedic Nursing 2005, 9:S1-11.
13. Weller C., Sussman G. Wound dressings update. Journal of Pharmacy Practice and Research 2006, 36:318-324.
14. Ovington L.G. Advances in wound dressings. Clinics in Dermatology 2007, 25:33-38.
15. Modified fibers with medical and specialty applications 2006, Springer, Dordrecht. V.B.-D. Edwards, Gisela, S. Goheen (Eds.).
16. Edwards J.V., Howley P., Davis R., Mashchak A., Goheen S.C. Protease inhibition by oleic acid transfer from chronic wound dressings to albumin. International Journal of Pharmaceutics 2007, 340:42-51.
17. Francart C., Dauchez M., Alix A.J.P., Lippens G. Solution structure of r-elafin, a specific inhibitor of elastase. Journal of Molecular Biology 1997, 268:666-677.
18. Tsunemi M., Kato H., Nishiuchi Y., Kumagaye S.-i., Sakakibara S. Synthesis and structure-activity relationships of elafin, an elastase-specific inhibitor. Biochemical and Biophysical Research Communications 1992, 185:967-973.
19. Tsunemi M., Matsuura Y., Sakakibara S., Katsube Y. Crystal structure of an elastase-specific inhibitor elafin complexed with porcine pancreatic elastase determined at 1.9Å resolution. Biochemistry 1996, 35:11570-11576.
20. Koizumi M., Fujino A., Fukushima K., Kamimura T., Takimoto-Kamimura M. Complex of human neutrophil elastase with 1/2SLPI. Journal of Synchrotron Radiation 2008, 15:308-311.
21. Moreau T., Baranger K., Dadé S., Dallet-Choisy S., Guyot N., Zani M.-L. Multifaceted roles of human elafin and secretory leukocyte proteinase inhibitor (SLPI), two serine protease inhibitors of the chelonianin family. Biochimie 2008, 90:284-295.
22. Li Z., Moy A., Sohal K., Dam C., Kuo P., Whittaker J., et al. Expression and characterization of recombinant human secretory leukocyte protease inhibitor (SLPI) protein from Pichia pastoris. Protein Expression and Purification 2009, 67:175-181.
23. Venge P., Byström J. Molecules in focus Eosinophil cationic protein (ECP). The International Journal of Biochemistry & Cell Biology 1998, 30:433-437.
24. Mohan C.G., Boix E., Evans H.R., Nikolovski Z., Nogues M.V., Cuchillo C.M., et al. The crystal structure of Eosinophil cationic protein in complex with 2',5'-ADP at 2.0Å resolution reveals the details of the ribonucleolytic active site. Biochemistry 2002, 41:12100-12106.
25. Boix E., Nikolovski Z., Moiseyev G.P., Rosenberg H.F., Cuchillo C.M., Nogues M.V. Kinetic and product distribution analysis of human eosinophil cationic protein indicates a subsite arrangement that favors exonuclease-type activity. Journal of Biological Chemistry 1999, 274:15605-15614.
26. Carreras E., Boix E., Rosenberg H.F., Cuchillo C.M., Nogues M.V. Both aromatic and cationic residues contribute to the membrane-lytic and bactericidal activity of eosinophil cationic protein. Biochemistry 2003, 42:6636-6644.
27. Temkin V., Aingorn H., Puxeddu I., Goldshmidt O., Zcharia E., Gleich G.J., et al. Eosinophil major basic protein: first identified natural heparanase-inhibiting protein. Journal of Allergy and Clinical Immunology 2004, 113:703-709.
28. Persson A., Rust K., Chang D., Moxley M., Longmore W., Crouch E. Cp4 - a pneumocyte-derived collagenous surfactant-associated protein - evidence for heterogeneity of collagenous surfactant proteins. Biochemistry 1988, 27:8576-8584.
29. Haczku A. Protective role of the lung collectins surfactant protein A and surfactant protein D in airway inflammation. Journal of Allergy and Clinical Immunology 2008, 122:861-879.
30. Kankavi O., Ata A., Celik-Ozenci C., Sati L., Ciftcioglu M.A., Demir R., et al. Presence and subcellular localizations of surfactant proteins A and D in human spermatozoa. Fertility and Sterility 2008, 90:1904-1909.
31. Kishore U., Greenhough T.J., Waters P., Shrive A.K., Ghai R., Kamran M.F., et al. Surfactant proteins SP-A and SP-D: structure, function and receptors. Molecular Immunology 2006, 43:1293-1315.
32. Holger W., Rudolf V.-E., Margit S., Marco S., Jens S.-M., Ulrich R. Coherent membrane supports for parallel microsynthesis and screening of bioactive peptides. Peptide Science 2000, 55:188-206.
33. Bieth J., Spiess B., Wermuth C.G. Synthesis and analytical use of a highly sensitive and convenient substrate of elastase. Biochemical Medicine 1974, 11:350-357.
34. Laemmli U.K. Cleavage of structural proteins during assembly of head of bacteriophage-T4. Nature 1970, 227:680-685.
35. Blom N., Gammeltoft S., Brunak S. Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. Journal of Molecular Biology 1999, 294:1351-1362.
36. Flotow H., Graves P.R., Wang A.Q., Fiol C.J., Roeske R.W., Roach P.J. Phosphate groups as substrate determinants for casein kinase I action. Journal of Biological Chemistry 1990, 265:14264-14269.
37. Oriano M., Flavio M., Stefania S., Monica A., Lorenzo A.P. Phosphorylation of synthetic fragments of inhibitor-2 of protein phosphatase-1 by casein kinase-1 and -2. European Journal of Biochemistry 1994, 223:647-653.
38. Meggio F., Perich J.W., Reynolds E.C., Pinna L.A. A synthetic [beta]-casein phosphopeptide and analogues as model substrates for casein kinase-1, a ubiquitous, phosphate directed protein kinase. FEBS Letters 1991, 283:303-306.
39. Koresawa M., Okabe T. High-throughput screening with quantitation of ATP consumption: a universal non-radioisotope, homogeneous assay for protein kinase. Assay and Drug Development Technologies 2004, 2:153-160.
40. Kupcho K., Somberg R., Bulleit B., Goueli S.A. A homogeneous, nonradioactive high-throughput fluorogenic protein kinase assay. Analytical Biochemistry 2003, 317:210-217.
41. Umezawa H., Aoyagi T., Okura A., Morishim H., Takeuchi T., Okami Y. Elastatinal a new elastase inhibitor produced by actinomycetes. Journal of Antibiotics 1973, 26:787-789.
42. Cook H., Stephens P., Davies K.J., Harding K.G., Thomas D.W. Defective extracellular matrix reorganization by chronic wound fibroblasts is associated with alterations in TIMP-1, TIMP-2, and MMP-2 activity. Journal of Investigative Dermatology 2000, 115:225-233.
43. Getie M., Schmelzer C.E.H., Neubert R.H.H. Characterization of peptides resulting from digestion of human skin elastin with elastase. Proteins: Structure, Function, and Bioinformatics 2005, 61:649-657.
44. Mecham R.P., Broekelmann T.J., Fliszar C.J., Shapiro S.D., Welgus H.G., Senior R.M. Elastin degradation by matrix metalloproteinases. Journal of Biological Chemistry 1997, 272:18071-18076.
45. Wang B., Malik R., Nigg E.A., Korner R. Evaluation of the low-specificity protease elastase for large-scale phosphoproteome analysis. Analytical Chemistry 2008, 80:9526-9533.
46. Vasconcelos A., Barros S., Cavaco-Paulo A. Switch on-switch off system for the inhibition of elastase on wound exudates. Proceedings 6th International Conference on Textile and Polymer Biotechnology 2009, 273-274.
47. Vasconcelos A., Pêgo A.P., Henriques L., Lamghari M., Cavaco-Paulo A. Protein matrices for improved wound healing: elastase inhibition by a synthetic peptide model. Biomacromolecules 2010, 11:2213-2220.